
|Videos|March 12, 2022
Augmenting corneal thickness with FDA-approved hypotonic riboflavin
Author(s)Alex Delaney-Gesing, Senior Editor
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.
Advertisement
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses his SECO 2022 presentation "Augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin," with Optometry Times®' Alex Delaney-Gesing.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Rapid ocular surface optimization in pre-op patients with cataract
2
PRIMA retinal implant restores vision in patients with advanced GA
3
Optometry pipeline watch: Key trial results and PDUFA dates for Q1 2026
4
Deseyne EDOF daily contact lenses first of its kind approved by US FDA
5














































